标题
Anti-IL5 therapy for asthma and beyond
作者
关键词
Eosinophil, IL-5, Eosinophilic asthma, Hypereosinophilic syndrome (HES), Churg-strauss syndrome, Chronic bronchitis, Eosinophilic granulamatosis and polyangitis (EGPA), Chronic obstructive pulmonary disorder (COPD), Mepolizumab, Reslizumab, Benralizumab
出版物
World Allergy Organization Journal
Volume 7, Issue 1, Pages 1-15
出版商
Springer Nature
发表日期
2014-12-04
DOI
10.1186/1939-4551-7-32
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia
- (2014) H. Ortega et al. EUROPEAN RESPIRATORY JOURNAL
- Innate lymphoid cells and asthma
- (2014) Sanhong Yu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti–Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma
- (2014) Parameswaran Nair NEW ENGLAND JOURNAL OF MEDICINE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art
- (2013) A. Vaglio et al. ALLERGY
- The consequences of not having eosinophils
- (2013) G. J. Gleich et al. ALLERGY
- Targeting Interleukin-5 in Refractory and Relapsing Churg–Strauss Syndrome
- (2013) Frank Moosig et al. ANNALS OF INTERNAL MEDICINE
- Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial
- (2013) H. Neighbour et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Development and function of group 2 innate lymphoid cells
- (2013) Jennifer A Walker et al. CURRENT OPINION IN IMMUNOLOGY
- Monoclonal antibodies for the treatment of refractory asthma
- (2013) Nathan Hambly et al. CURRENT OPINION IN PULMONARY MEDICINE
- What is an “eosinophilic phenotype” of asthma?
- (2013) Parameswaran Nair JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
- (2013) Michel Laviolette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TH2, allergy and group 2 innate lymphoid cells
- (2013) Paula Licona-Limón et al. NATURE IMMUNOLOGY
- Eosinophils in the Spotlight: Eosinophilic airway inflammation in nonallergic asthma
- (2013) Guy G Brusselle et al. NATURE MEDICINE
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted therapy of bronchitis in obstructive airway diseases
- (2013) Angira Dasgupta et al. PHARMACOLOGY & THERAPEUTICS
- Eosinophilic Pneumonias
- (2012) P. Akuthota et al. CLINICAL MICROBIOLOGY REVIEWS
- How to Diagnose and Phenotype Asthma
- (2012) Parameswaran Nair et al. CLINICS IN CHEST MEDICINE
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- The potential of biologics for the treatment of asthma
- (2012) Girolamo Pelaia et al. NATURE REVIEWS DRUG DISCOVERY
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-4 and interleukin-13 prime migrational responses of haemopoietic progenitor cells to stromal cell-derived factor-1α
- (2011) N. Punia et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma
- (2011) Aasia Ghazi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Eosinophils in health and disease: the LIAR hypothesis
- (2010) J. J. Lee et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
- (2010) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sustained response to mepolizumab in refractory Churg-Strauss syndrome
- (2010) Jean-Emmanuel Kahn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A review of treatment with mepolizumab, an anti–IL-5 mAb, in hypereosinophilic syndromes and asthma
- (2010) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
- (2010) Florence Roufosse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
- (2010) Sophia Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human airway smooth muscle promotes eosinophil differentiation
- (2009) A. I. Fanat et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Therapy against CCR3 and the Common Beta Chain Attenuates Allergen-induced Eosinophilic Responses
- (2008) Gail M. Gauvreau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
- (2008) Marc E. Rothenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now